The Effect of Dextroamphetamine on Attention, Mood and Functional Recovery in Acute Traumatic Brain Injury: A Randomized, Placebo-Controlled Pilot Study

Project Type
Independent
Principal Investigator Name
John Whyte, MD, Ph.D. & Thomas Watanabe, M.D.
Principal Investigator Email
Start Date:
10/1/2007
End Date:
9/30/2012
Participating Centers:
Target Population(s):
TBI
Project Website:
Abstract:
This project is a placebo-controlled pilot study of the effects of dextroamphetamine (DEX) on attention, engagement in therapy, cognitive and motor speed, and other outcomes in subacute TBI. We will also examine the possibility that DEX accelerates the pace of functional recovery in the subacute phase.